Past Medical History: CAD ARF asthma COPD HTN squamous cell CA LBBB NSTEMI [**2155**] vision loss left eye endometriosis   Social History: remote tobacco use lives alone [**1-25**] martinis per night  Family History: son with CAD/stents at age 65  Physical Exam: 5'2"    97 #   159/70  RR 20 skin/HEENT unremarkable neck supple, full ROM CTAB RRR, no murmur soft, NT, ND, + BS warm,well-perfused 1+ edema no obvious varicosities neuro grossly intact 2+ bilat.
POST-BYPASS: For the post-bypass study, the patient was receiving vasoactive infusions including phenylephrine and epinephrine and is being AV paced.
Other findings are unchanged   I certify that I was present for this procedure in compliance with HCFA regulations.
Electronically signed by [**Name6 (MD) 928**] [**Name8 (MD) 929**], MD, MD, Interpreting physician [**Last Name (NamePattern4) **] [**2158-5-17**] 11:57  Final Report  CT ABDOMEN W/O CONTRAST  [**2158-5-26**] 1:01 PM  CT CHEST W/O CONTRAST; CT ABDOMEN W/O CONTRAST  Reason: r/o infection source Field of view: 36  [**Hospital 93**] MEDICAL CONDITION: 88 year old woman with s/p CABG REASON FOR THIS EXAMINATION: r/o infection source CONTRAINDICATIONS for IV CONTRAST: None.
However, an infectious process cannot be entirely excluded for the parenchymal opacities and followup after treatment is recommended to ensure resolution.
infiltrate, check line position CHEST  HISTORY: CABG, elevate white blood count cell count subclavian line placement.
The patient is status post median sternotomy, and mediastinal structures are unchanged.
A tracheostomy tube and left PICC line remain in place.
A right- sided central line has been withdrawn.
A right subclavian catheter has been introduced and terminates at the level of the cavoatrial junction.
IMPRESSION: Line placement as described.
IV NTG continued and IV heaprin started for recurrent angina.
She had a cardiac arrest requiring CPR during line placement and an emergency CABG x2 done by Dr. [**First Name (STitle) **].
Developed Afib on [**5-16**] treated with amiodarone.
Unable to wean from vent.Dobhoff tube placed.
Lasix drip started.
Mutiple skin tears noted and wound care nurse as well as plastic surgery consulted.
IV heparin restarted on POD #7.
Tube feeds started the following day.
IV flagyl/PO vanco started for preseumed colitis and cipro continued for 7 days for serratia in sputum.
Right thoracentesis for 650 cc done on POD #18.
[**6-5**]: a mild ileus was noted and TF were backed off, trophic continued, and plan to advance with ileus resolution.
Beta blockers and amiodarone dc'd for bradycardia.
She was started on cefepime for GNR in sputum.
She was again started on tube feeds and her TPN was discontinued.
Her BUN/Cr were continuing to rise however family did not want dialysis and understood risks therin.
Medications on Admission: advair 2 puffs daily singulair 10 mg daily lopressor 12.5 mg [**Hospital1 **] ASA 81 mg daily trusopt 2% one gtt OU TID albuterol MDI 2 puffs TID  atrovent 2 puffs TID lipitor 5 mg daily lisinopril 10 mg daily nephrocaps  Discharge Medications: 1.
Chlorhexidine Gluconate 0.12 % Mouthwash Sig: Fifteen (15) ML Mucous membrane [**Hospital1 **] (2 times a day).
Acetaminophen 650 mg Tablet Sig: 1-2 Tablets PO Q4H (every 4 hours) as needed for temperature >38.0.
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Dorzolamide 2 % Drops Sig: One (1) Drop Ophthalmic TID (3 times a day).
Therapeutic Multivitamin     Liquid Sig: Five (5) ML PO DAILY (Daily).
Zinc Sulfate 220 mg Capsule Sig: One (1) Capsule PO DAILY (Daily).
Beclomethasone Dipropionate 80 mcg/Actuation Aerosol Sig: One (1)  Inhalation [**Hospital1 **] (2 times a day).
Ipratropium Bromide 17 mcg/Actuation Aerosol Sig: Six (6) Puff Inhalation QID (4 times a day).
Albuterol 90 mcg/Actuation Aerosol Sig: Six (6) Puff Inhalation Q4H (every 4 hours).
Atorvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Heparin (Porcine) 5,000 unit/mL Solution Sig: One (1) Injection TID (3 times a day).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Insulin Glargine 100 unit/mL Solution Sig: Ten (10) units Subcutaneous HS (at bedtime).
Amiodarone 200 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Levothyroxine 50 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Miconazole Nitrate 2 % Powder Sig: One (1) Appl Topical TID (3 times a day).
Bisacodyl 10 mg Suppository Sig: One (1) Suppository Rectal [**Hospital1 **] (2 times a day).
Procrit 4,000 unit/mL Solution Sig: One (1)  Injection mon, wed,.fri.
Vancomycin 250 mg Capsule Sig: One (1) Capsule PO Q6H (every 6 hours): Vancomycin Oral Liquid 250 mg PO Q6H through [**6-21**].
Cefepime 1 gram Recon Soln Sig: One (1) Recon Soln Injection Q24H (every 24 hours): through [**6-14**].
Metronidazole in NaCl (Iso-os) 500 mg/100 mL Piggyback Sig: Five Hundred (500) mg Intravenous Q8H (every 8 hours): through [**6-21**].
Sodium Chloride 0.9%  Flush 10 mL IV PRN line flush Temporary Central Access-ICU: Flush with 10mL Normal Saline daily and PRN.
Metoclopramide 5 mg IV Q6H   Discharge Disposition: Extended Care  Facility: [**Hospital6 1293**] - [**Location (un) 1294**]  Discharge Diagnosis: CAD s/p cabg x2 post op respiratory failure s/p tracheostomy/PEG tube placement post op acute renal failure, acute tubular necrosis cardiac arrest asthma COPD HTN squamous cell CA LBBB NSTEMI [**2155**] vision loss left eye endometriosis PNA   Discharge Condition: stable   Discharge Instructions: Call with fever, redness or drainage from incision or weight gain more than 2 pounds in one day or five in one week.
Shower, no baths, no lotions, creams or powders to incisions.
Followup Instructions: see Dr. [**Last Name (STitle) 66572**] 1-2 weeks after discharge from rehab see Dr. [**Last Name (STitle) **] 2-3 weeks after discharge from rehab see Dr. [**First Name (STitle) **] in 4 weeks after discharge from rehab                                [**Name6 (MD) **] [**Name8 (MD) **] MD [**MD Number(2) 173**]  Completed by:[**2158-6-13**
